Description

Sleep Spray (DSIP + Melatonin) Peptide Nasal Spray

Sleep Spray (DSIP & Melatonin) contains 5mg DSIP & 100mg Melatonin, a total of 1.05mg per spray, and 105mg in total.

Melatonin
CAS Number	73-31-4
Molar Mass	232.283 g/mol
Chemical Formula	C13H16N2O2
IUPAC Name	N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide

Delta sleep-inducing peptide
CAS Number	62568-57-4
Molar Mass	848.8 g/mol
Chemical Formula	C35H48N10O15
IUPAC Name	DL-tryptophyl-DL-alanyl-glycyl-glycyl-DL-alpha-aspartyl-DL-alanyl-DL-seryl-glycyl-DL-glutamic acid

Introduction

DSIP + Melatonin is a research compound expressly formulated for scientific investigations and is strictly not intended for human consumption. This combination comprises Delta Sleep-Inducing Peptide (DSIP) and Melatonin, presenting an intriguing avenue for research into potential synergies and applications related to sleep and associated conditions.

Please note: Subjects reported a sensation of burning associated with the nasal spray, shedding light on potential sensory effects. However, this sensation tends to dissipate rapidly in subjects.

Key Characteristics

The key characteristics of DSIP + Melatonin lie in the combination of DSIP, known for its role in sleep regulation, and Melatonin, a hormone associated with circadian rhythm and sleep-wake cycles. Researchers are exploring the unique qualities and potential synergies arising from this combination.

Research Applications

Scientists are actively exploring the research applications of DSIP + Melatonin, particularly in the realm of sleep regulation, insomnia, and related conditions. This combination presents an opportunity to delve into the potential interactions between DSIP and Melatonin in a controlled research environment.

Research Benefits

DSIP + Melatonin Synergistic Potential

Preliminary studies suggest that the combination of DSIP and Melatonin may have synergistic effects on sleep-related processes. Ongoing research endeavors aim to uncover the mechanisms behind this synergy and its potential applications in the context of sleep regulation.

Delta Sleep-Inducing Peptide and Insomnia

DSIP, known for its involvement in sleep regulation, is being investigated for its potential role in addressing insomnia. Research studies are exploring whether DSIP, in combination with Melatonin, could offer insights into novel approaches for managing sleep disorders.

Melatonin on Fibromyalgia

Melatonin’s role in managing conditions such as fibromyalgia is under scrutiny in ongoing research. Investigations aim to understand the potential benefits of Melatonin, both independently and in combination with DSIP, in addressing symptoms associated with fibromyalgia.

Summary

DSIP + Melatonin, tailored for research purposes, is a subject of ongoing scientific inquiry. Researchers are actively exploring its potential synergies and applications in sleep regulation, insomnia, and conditions like fibromyalgia within controlled research settings.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Dietrich Schneider-Helmert; Effects of Delta-Sleep-Inducing Peptide on 24-Hour Sleep-Wake Behaviour in Severe Chronic Insomnia. Eur Neurol 1 February 1987; 27 (2): 120–129. https://doi.org/10.1159/000116143. [Read More].
2. Danilov, A., Kurganova, J. Melatonin in Chronic Pain Syndromes. Pain Ther 5, 1–17 (2016). https://doi.org/10.1007/s40122-016-0049-y. [Read More]